Join Michael Hochman, MD, MPH, for the second episode of Updates in Slow Medicine. This installment discusses results from a recent study that raises the possibility that a…
NEW YORK (Reuters Health) – Cardiac resynchronization therapy not only reduces the risk of a first heart failure event but also recurring events, according to an analysis of…
NEW YORK (Reuters Health) – For STEMI patients with multivessel coronary disease undergoing primary percutaneous coronary intervention, outcomes are better when revascularization is targeted to just the culprit…
NEW YORK (Reuters Health) – One-year survival after transcatheter aortic valves implantation in otherwise inoperable patients is “excellent” according to a new report. The findings, reported in the…
NEW YORK (Reuters Health) – Women with a history of an atrial switch procedure for congenital d-transposition of the great arteries are at risk of untoward pregnancy outcomes,…
NEW YORK (Reuters Health) – Among patients with atrial fibrillation on amiodarone, the incidence of thyroid dysfunction is identical in those taking the brand-name formulation of the drug…
NEW YORK (Reuters Health) – Giving elderly patients with acute MI a clopidogrel loading dose of 300 mg or more rather than a lower conventional dose doesn’t increase…
NEW YORK (Reuters Health) – A new population-based study finds the incidence of pulmonary complications associated with amiodarone to be relatively low, but still 50% higher among patients…
NEW YORK (Reuters Health) – African Americans are less likely to develop atrial fibrillation after isolated coronary artery bypass graft (CABG) surgery than European Americans, a new study…
NEW YORK (Reuters Health) – Patients with unprotected left main disease and right coronary artery chronic total occlusion (CTO) undergoing percutaneous coronary intervention (PCI) face an increased risk…
NEW YORK (Reuters Health) – Facilitated percutaneous coronary intervention (PCI), with prehospital fibrinolysis, is no better than primary PCI for patients who are very early in the course…
